Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases

Pharmacol Ther. 2022 Nov:239:108208. doi: 10.1016/j.pharmthera.2022.108208. Epub 2022 May 13.

Abstract

As the first line of defence in the lung, alveolar macrophage contributes to maintaining lung immune homoeostasis. Characterized by the heterogeneity and plasticity, macrophages polarize into two pro-inflammatory and anti-inflammatory phenotypes regarding the biological and pathological environment. In the past decade, numerous studies have revolutionized the relationship between cellular metabolism and macrophage functions. Mitochondria dysfunctions, which results in altered cellular metabolic profile, were observed in the alveolar macrophages during chronic lung diseases. In addition, alveolar macrophages adapt metabolic reprogramming to produce an immune response against the pathogens. Here, we outline the role of mitochondria in the development of macrophage phenotypes and functions and highlight the mitochondrial dysfunction in the setting of chronic lung diseases. Lastly, we emphasize the therapeutic relevance of targeting metabolic pathways in alveolar macrophages, which may shed light on developing novel strategies against chronic lung diseases.

Keywords: Chronic lung disease; Macrophage; Macrophage polarization; Metabolic reprogramming; Mitochondria metabolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lung / metabolism
  • Lung Diseases* / metabolism
  • Macrophages* / metabolism
  • Macrophages, Alveolar
  • Mitochondria / metabolism